FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321879481> ?p ?o ?g. }

• W2321879481 endingPage "4498" @default.
• W2321879481 startingPage "4494" @default.
• W2321879481 abstract "ErbB4 can act as either a tumor-suppressor gene or an oncogene in breast cancer. Multiple genetic factors including single nucleotide polymorphisms (SNPs) affect gene expression patterns. Multiple 3'-untranslated region (3'-UTR) SNPs reside within the target binding site of microRNAs, which can strengthen or weaken binding to target genes. The present study aimed to predict potential 3'‑UTR variants of ErbB4 that alter the target binding site of microRNAs (miRNAs) and to clarify the association of the potential variant with the risk of developing breast cancer. In silico prediction was performed to identify potential functional SNPs within miRNA target binding sites in the 3'‑UTR of ErbB4. Thus, 146 patients and controls were genotyped using restriction fragment length polymorphism-polymerase chain reaction. In addition to the Cochran-Armitage test for trend, allele and genotype frequency differences were determined to investigate the association between rs1836724 and the susceptibility to breast cancer. Bioinformatics analysis identified rs1836724 to be a polymorphism in the seed region of four miRNA binding sites (hsa-miR335-5p, hsa-miR-28-5p, has‑miR‑708‑5p and has‑miR‑665), which may participate in the development of breast cancer. Logistic regression data indicated that the T allele of the polymorphism [OR (95% CI)=1.72 (1.056‑2.808), P=0.029] is associated with the risk of breast cancer. Using bioinformatics tools, a correlation was indicated between the presence of the T allele and a reduction in ErbB4 RNA silencing based on miRNA interaction. Furthermore, case subgroup data analysis revealed an association between the C/T genotype and an ER positive phenotype [OR (95% CI)=6.00 (1.082‑33.274), P=0.028] compared with the T/T genotype. ErbB4 and estrogen receptor 1 (ESR1) are regulated by identical miRNAs thus there may be a competition for binding sites. Due to this pattern, if the interaction between miRNAs with one gene is reduced, it may be consistent with the increase in interaction with another one. Therefore, more interaction with rs1836724 C variant within ErbB4 may be associated with higher expression of ESR1 (ER‑positive phenotype). miRNAs interact with ErbB4 mRNA more frequently when it carries C allele at the rs1836724 position compared with the T carriers. Therefore, the identical miRNA interacts with ESR1 less frequently when ErbB4 mRNA has a C allele. Therefore, ESR1 expression may be higher when ErbB4 mRNA has a C allele." @default.
• W2321879481 created "2016-06-24" @default.
• W2321879481 creator A5032766708 @default.
• W2321879481 creator A5045958617 @default.
• W2321879481 creator A5047529047 @default.
• W2321879481 creator A5060115312 @default.
• W2321879481 creator A5061938509 @default.
• W2321879481 date "2016-03-31" @default.
• W2321879481 modified "2023-10-11" @default.
• W2321879481 title "Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3′-untranslated region of ErbB4 in breast cancer" @default.
• W2321879481 cites W1525625308 @default.
• W2321879481 cites W156316974 @default.
• W2321879481 cites W1734706036 @default.
• W2321879481 cites W1963511219 @default.
• W2321879481 cites W1984397688 @default.
• W2321879481 cites W1994548165 @default.
• W2321879481 cites W2012915718 @default.
• W2321879481 cites W2021687020 @default.
• W2321879481 cites W2021700900 @default.
• W2321879481 cites W2032605043 @default.
• W2321879481 cites W2035192299 @default.
• W2321879481 cites W2054443407 @default.
• W2321879481 cites W2056051244 @default.
• W2321879481 cites W2077456128 @default.
• W2321879481 cites W2101117089 @default.
• W2321879481 cites W2104948370 @default.
• W2321879481 cites W2106787323 @default.
• W2321879481 cites W2115440941 @default.
• W2321879481 cites W2123415105 @default.
• W2321879481 cites W2128331754 @default.
• W2321879481 cites W2140840142 @default.
• W2321879481 cites W2151519667 @default.
• W2321879481 cites W2160859576 @default.
• W2321879481 cites W2160875588 @default.
• W2321879481 cites W2167144418 @default.
• W2321879481 doi "https://doi.org/10.3892/mmr.2016.5078" @default.
• W2321879481 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27035115" @default.
• W2321879481 hasPublicationYear "2016" @default.
• W2321879481 type Work @default.
• W2321879481 sameAs 2321879481 @default.
• W2321879481 citedByCount "22" @default.
• W2321879481 countsByYear W23218794812016 @default.
• W2321879481 countsByYear W23218794812017 @default.
• W2321879481 countsByYear W23218794812018 @default.
• W2321879481 countsByYear W23218794812019 @default.
• W2321879481 countsByYear W23218794812020 @default.
• W2321879481 countsByYear W23218794812021 @default.
• W2321879481 countsByYear W23218794812022 @default.
• W2321879481 countsByYear W23218794812023 @default.
• W2321879481 crossrefType "journal-article" @default.
• W2321879481 hasAuthorship W2321879481A5032766708 @default.
• W2321879481 hasAuthorship W2321879481A5045958617 @default.
• W2321879481 hasAuthorship W2321879481A5047529047 @default.
• W2321879481 hasAuthorship W2321879481A5060115312 @default.
• W2321879481 hasAuthorship W2321879481A5061938509 @default.
• W2321879481 hasBestOaLocation W23218794811 @default.
• W2321879481 hasConcept C104317684 @default.
• W2321879481 hasConcept C105580179 @default.
• W2321879481 hasConcept C119056186 @default.
• W2321879481 hasConcept C121608353 @default.
• W2321879481 hasConcept C135763542 @default.
• W2321879481 hasConcept C145059251 @default.
• W2321879481 hasConcept C153209595 @default.
• W2321879481 hasConcept C180754005 @default.
• W2321879481 hasConcept C22667442 @default.
• W2321879481 hasConcept C2781018059 @default.
• W2321879481 hasConcept C29537977 @default.
• W2321879481 hasConcept C502942594 @default.
• W2321879481 hasConcept C530470458 @default.
• W2321879481 hasConcept C54355233 @default.
• W2321879481 hasConcept C86803240 @default.
• W2321879481 hasConcept C89604277 @default.
• W2321879481 hasConceptScore W2321879481C104317684 @default.
• W2321879481 hasConceptScore W2321879481C105580179 @default.
• W2321879481 hasConceptScore W2321879481C119056186 @default.
• W2321879481 hasConceptScore W2321879481C121608353 @default.
• W2321879481 hasConceptScore W2321879481C135763542 @default.
• W2321879481 hasConceptScore W2321879481C145059251 @default.
• W2321879481 hasConceptScore W2321879481C153209595 @default.
• W2321879481 hasConceptScore W2321879481C180754005 @default.
• W2321879481 hasConceptScore W2321879481C22667442 @default.
• W2321879481 hasConceptScore W2321879481C2781018059 @default.
• W2321879481 hasConceptScore W2321879481C29537977 @default.
• W2321879481 hasConceptScore W2321879481C502942594 @default.
• W2321879481 hasConceptScore W2321879481C530470458 @default.
• W2321879481 hasConceptScore W2321879481C54355233 @default.
• W2321879481 hasConceptScore W2321879481C86803240 @default.
• W2321879481 hasConceptScore W2321879481C89604277 @default.
• W2321879481 hasIssue "5" @default.
• W2321879481 hasLocation W23218794811 @default.
• W2321879481 hasLocation W23218794812 @default.
• W2321879481 hasOpenAccess W2321879481 @default.
• W2321879481 hasPrimaryLocation W23218794811 @default.
• W2321879481 hasRelatedWork W1605218324 @default.
• W2321879481 hasRelatedWork W2029260884 @default.
• W2321879481 hasRelatedWork W2050159684 @default.
• W2321879481 hasRelatedWork W2066198055 @default.
• W2321879481 hasRelatedWork W2073461718 @default.

• next